Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/03/2000DE19903241A1 Galenische Formulierung Drug formulation
08/03/2000DE19903095A1 Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium Production of gamma-linolenic acid from protozoa of the genus Colpidium
08/03/2000DE19902924A1 Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen Use of organophosphorus compounds in the prophylactic and therapeutic treatment of infections
08/03/2000DE19901921A1 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels Polymorphs of telmisartan, to processes for their preparation and their use for the preparation of a medicament
08/03/2000DE10003771A1 Treating cardiac infarction-induced damage to myocardium, using moxonidine to restore or rehabilitate myocardial state after infarction
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2396005A1 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
08/03/2000CA2361621A1 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361516A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
08/03/2000CA2361268A1 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000CA2361260A1 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000CA2361256A1 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2361239A1 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000CA2360997A1 Non-invasive method for detecting target rna
08/03/2000CA2360790A1 Mono-acyloxy aralkyl neuromuscular relaxants
08/03/2000CA2360691A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
08/03/2000CA2360689A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
08/03/2000CA2360687A1 Composition and method for treating diabetes
08/03/2000CA2360683A1 Antidepressant heterocyclic compounds
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360672A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2360661A1 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000CA2360600A1 A method of controlling fungal pathogens, and agents useful for same
08/03/2000CA2360085A1 Genes identified as required for proliferation in escherichia coli
08/03/2000CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000CA2359711A1 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
08/03/2000CA2359317A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2359011A1 Thiazolopyrimidine compound, its production and use
08/03/2000CA2358967A1 Hesperitin pro-forms with enhanced bioavailability
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2357709A1 Internal ribosome entry site (ires), vector containing same and uses thereof
08/03/2000CA2357525A1 Treating cancers associated with overexpression of her-2/neu
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000CA2325887A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
08/03/2000CA2296936A1 Novel core 2 beta-1,6-n-acetylglycosaminyltransferase
08/02/2000EP1024199A2 Recovery of gamma-linolenic acid from protozoa of the genus Colpidium
08/02/2000EP1024198A2 Pseudo-adenoviral vectors for the gene therapy of haemophiliae
08/02/2000EP1024197A2 Mesothelial cell gene therapy
08/02/2000EP1024150A1 Process for producing cationic polymer
08/02/2000EP1024148A1 Dextran reduced in boron content, process for producing the same, and dextran packed in container in solution state
08/02/2000EP1024146A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds
08/02/2000EP1024145A2 Novel azalides and methods of making same
08/02/2000EP1024138A1 Pyrazole derivatives
08/02/2000EP1024137A1 Resolution of amines
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023907A1 Medicinal compositions with cholesterol-lowering effect
08/02/2000EP1023899A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
08/02/2000EP1023898A1 Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands
08/02/2000EP1023897A2 Dermal agent
08/02/2000EP1023896A2 Opioid formulations for treating pain
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023443A1 Mammoglobin homolog
08/02/2000EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function
08/02/2000EP1023435A2 Novel lactic acid bacteria species
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023315A1 Methods and compositions for destruction of selected proteins
08/02/2000EP1023314A1 Bile acid salts of metals with physiological action and the use thereof in therapy
08/02/2000EP1023313A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
08/02/2000EP1023308A1 Inhibitors of nucleoside metabolism
08/02/2000EP1023302A1 Binuclear complex
08/02/2000EP1023301A1 A heterocyclic chemical compound
08/02/2000EP1023299A1 Combined generation of phosphinic acid derivatives
08/02/2000EP1023296A1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
08/02/2000EP1023295A1 Fibrinogen receptor antagonist prodrugs
08/02/2000EP1023294A1 Carbapenem derivatives and a preparation method thereof
08/02/2000EP1023293A1 Aryloxymethyl carbapenem antibacterials
08/02/2000EP1023291A1 Dipyridoimidazolderivatives useful in treating central nervous system disorders
08/02/2000EP1023290A1 Synthesis of swainsonine salts
08/02/2000EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
08/02/2000EP1023287A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
08/02/2000EP1023286A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023284A2 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
08/02/2000EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
08/02/2000EP1023281A1 Hiv integrase inhibitors
08/02/2000EP1023279A2 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/02/2000EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
08/02/2000EP1023274A1 An efficient method for the conversion of nitriles to amidines
08/02/2000EP1023273A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
08/02/2000EP1023269A1 Beta3-adrenoreceptor agonists, agonist compositions and methods of using
08/02/2000EP1023268A1 Isoquinolines as urokinase inhibitors
08/02/2000EP1023267A1 Pyridyl compounds and pharmaceutical compositions containing them
08/02/2000EP1023266A2 Process for making diaryl pyridines useful as cox-2 inhibitors
08/02/2000EP1023265A1 Azetidinone derivatives for the treatment of hcmv infections
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023251A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
1 ... 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 6285 6286 6287 6288 6289 ... 7860